Formation of p-n homogeneous junctions
    1.
    发明授权
    Formation of p-n homogeneous junctions 有权
    形成p-n均质结

    公开(公告)号:US07768003B2

    公开(公告)日:2010-08-03

    申请号:US11855568

    申请日:2007-09-14

    IPC分类号: H01L29/10

    摘要: Methods, structures and devices are described, in which structures and devices have one or more p-n homo-junctions fabricated in solution. The junctions are formed by a sequential deposition of an oxide of copper from solution. Conduction type of the oxide of copper is controlled by pH of the solution.

    摘要翻译: 描述了方法,结构和装置,其中结构和装置在溶液中制造了一个或多个p-n均聚点。 通过从溶液中顺次沉积铜的氧化物形成结。 铜的氧化物的传导类型由溶液的pH控制。

    Formation of p-n homogeneous junctions
    2.
    发明申请
    Formation of p-n homogeneous junctions 有权
    形成p-n均质结

    公开(公告)号:US20090072231A1

    公开(公告)日:2009-03-19

    申请号:US11855568

    申请日:2007-09-14

    IPC分类号: H01L31/032 H01L31/18

    摘要: Methods, structures and devices are described, in which structures and devices have one or more p-n homo-junctions fabricated in solution. The junctions are formed by a sequential deposition of an oxide of copper from solution. Conduction type of the oxide of copper is controlled by pH of the solution.

    摘要翻译: 描述了方法,结构和装置,其中结构和装置在溶液中制造了一个或多个p-n均聚点。 通过从溶液中顺次沉积铜的氧化物形成结。 铜的氧化物的传导类型由溶液的pH控制。

    INHIBITORS OF BRUTON'S TYROSINE KINASE
    3.
    发明申请
    INHIBITORS OF BRUTON'S TYROSINE KINASE 有权
    BRUTON的酪氨酸激酶抑制剂

    公开(公告)号:US20160031891A1

    公开(公告)日:2016-02-04

    申请号:US14814779

    申请日:2015-07-31

    IPC分类号: C07D487/04

    CPC分类号: C07D487/04 A61K31/4162

    摘要: Disclosed herein are amido compounds that form covalent bonds with Bruton's tyrosine kinase (Btk). Also described are irreversible inhibitors of Btk. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the Btk inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.

    摘要翻译: 本文公开了与Bruton酪氨酸激酶(Btk)形成共价键的酰氨基化合物。 还描述了Btk的不可逆抑制剂。 还公开了包含化合物的药物组合物。 公开了使用Btk抑制剂的方法,单独或与其它治疗剂组合用于治疗自身免疫性疾病或病症,异种免疫疾病或病症,癌症,包括淋巴瘤和炎性疾病或病症。